Business Wire

PharmaJet Tropis Intradermal Delivery System is Now Authorized for Two Nucleic Acid Vaccines

First human DNA vaccine First in class thermostable self-amplifying mRNA vaccine GOLDEN, Colo.--(BUSINESS WIRE)--PharmaJet ®, a company engineering precision delivery systems that overcome challenges ...

NanoPass Technologies Expands Product Portfolio to Advance Intradermal Delivery

NanoPass Technologies Ltd., a global leader in intradermal delivery solutions, will officially launch MicronJet™ 800 during IMCAS World 2026, taking place January 29 – 31, 2026, in Paris.
Morningstar

Publication in Vaccines Highlights Important Benefits of PharmaJet® Tropis® Intradermal Vaccination over Intramuscular Standard of Care

Tropis ID, a WHO pre-qualified needle-free delivery system, is an easy-to-use, precise, intradermal delivery method that has already been successfully used in campaign and house-to-house settings in ...
Business Wire

PharmaJet to Highlight Benefits of Needle-free Intradermal Delivery at Medical Conference in Ethiopia

PharmaJet presentation will highlight the results of recent immunization studies using needle-free intradermal (ID) delivery for polio immunization campaigns. Data reinforces how increased coverage, ...